{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:16:51Z","timestamp":1792333011418,"version":"4.4.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/brain\/awx310","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T17:11:22Z","timestamp":1509556282000},"page":"165-176","source":"Crossref","is-referenced-by-count":203,"title":["In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease"],"prefix":"10.1093","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9645-0812","authenticated-orcid":false,"given":"Nicola J","family":"Ray","sequence":"first","affiliation":[{"name":"Department of Psychology, Manchester Metropolitan University, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Bradburn","sequence":"additional","affiliation":[{"name":"School of Healthcare Science, Manchester Metropolitan University, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Murgatroyd","sequence":"additional","affiliation":[{"name":"School of Healthcare Science, Manchester Metropolitan University, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Toseeb","sequence":"additional","affiliation":[{"name":"Department of Education, Derwent College, University of York, York, YO10 5DD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[{"name":"Unidad de Trastornos del Movimiento, Servicio de Neurolog\u00eda y Neurofisiolog\u00eda Cl\u00ednica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc\u00edo\/Csubstantia innominataC\/Universidad de Sevilla, Sevilla, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K","family":"Kountouriotis","sequence":"additional","affiliation":[{"name":"Department of Psychology, Manchester Metropolitan University, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J","family":"Teipel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany"},{"name":"German Center for Neurodegenerative Diseases (DZNE) \u2013 Rostock\/Greifswald, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel J","family":"Grothe","sequence":"additional","affiliation":[{"name":"German Center for Neurodegenerative Diseases (DZNE) \u2013 Rostock\/Greifswald, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"key\n\t\t\t\t20180226040359_awx310-B1","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.neurobiolaging.2011.06.014","article-title":"Hippocampal and ventricular changes in Parkinson\u2019s disease mild cognitive impairment","volume":"33","author":"Apostolova","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180226040359_awx310-B3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.mri.2009.01.006","article-title":"Computational anatomy with the SPM software","volume":"27","author":"Ashburner","year":"2009","journal-title":"Magn Reson Imaging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G","article-title":"Nonlinear spatial normalization using basis functions","volume":"7","author":"Ashburner","year":"1999","journal-title":"Hum Brain Mapp"},{"key":"key\n\t\t\t\t20180226040359_awx310-B5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/cns.12417","article-title":"Resting-state functional brain networks in Parkinson\u2019s disease","volume":"21","author":"Baggio","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"key\n\t\t\t\t20180226040359_awx310-B6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.0b013e3181b0bd3d","article-title":"Cholinergic denervation occurs early in Parkinson disease","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180226040359_awx310-B10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","article-title":"Heterogeneity of cholinergic denervation in Parkinson\u2019s disease without dementia","volume":"32","author":"Bohnen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20180226040359_awx310-B11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","article-title":"Pathological changes in the nucleus of Meynert in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"59","author":"Candy","year":"1983","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180226040359_awx310-B12","doi-asserted-by":"crossref","first-page":"e0175674","DOI":"10.1371\/journal.pone.0175674","article-title":"Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease","volume":"12","author":"Caspell-Garcia","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180226040359_awx310-B13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.22271","article-title":"Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease","volume":"69","author":"Chen-Plotkin","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2010.11.015","article-title":"Volumetric analysis of the substantia innominata in patients with Parkinson\u2019s disease according to cognitive status","volume":"33","author":"Choi","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/mp.2015.6","article-title":"Genetic overlap between Alzheimer\u2019s disease and Parkinson\u2019s disease at the MAPT locus","volume":"20","author":"Desikan","year":"2015","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ane.12375","article-title":"Cognitive function in the early phase of Parkinson\u2019s disease, a five-year follow-up","volume":"132","author":"Domell\u00f6f","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20180226040359_awx310-B17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00415-004-0549-2","article-title":"Cognitive and SPECT characteristics predict progression of Parkinson\u2019s disease in newly diagnosed patients","volume":"251","author":"Dujardin","year":"2004","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/brain\/awh067","article-title":"The cognitive ability of an incident cohort of Parkinson\u2019s patients in the UK. The CamPaIGN study","volume":"127","author":"Foltynie","year":"2004","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneurol.2009.102","article-title":"Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation","volume":"66","author":"Freund","year":"2009","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B21","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/brain\/awu159","article-title":"Grey matter hypometabolism and atrophy in Parkinson\u2019s disease with cognitive impairment: a two-step process","volume":"137","author":"Gonz\u00e1lez-Redondo","year":"2014","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B22","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.neubiorev.2013.09.003","article-title":"The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?","volume":"37","author":"Gratwicke","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"key\n\t\t\t\t20180226040359_awx310-B23","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","article-title":"Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer\u2019s disease","volume":"34","author":"Grothe","year":"2013","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2011.06.019","article-title":"Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer\u2019s disease","volume":"71","author":"Grothe","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cercor\/bhp232","article-title":"Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer\u2019s disease","volume":"20","author":"Grothe","year":"2010","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20180226040359_awx310-B26","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/j.jalz.2013.09.011","article-title":"Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects","volume":"10","author":"Grothe","year":"2014","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20180226040359_awx310-B27","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/cercor\/bhv062","article-title":"Cognitive correlates of basal forebrain atrophy and associated cortical hypometabolism in mild cognitive impairment","volume":"26","author":"Grothe","year":"2016","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20180226040359_awx310-B28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/brain\/awu036","article-title":"Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally","volume":"137","author":"Hanganu","year":"2014","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B30","doi-asserted-by":"crossref","first-page":"e0175560","DOI":"10.1371\/journal.pone.0175560","article-title":"Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson\u2019s disease","volume":"12","author":"Huertas","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180226040359_awx310-B31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.20974","article-title":"Subtypes of mild cognitive impairment in Parkinson\u2019s disease: progression to dementia","volume":"21","author":"Janvin","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2008.03.005","article-title":"Impaired cognitive performance in Parkinson\u2019s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy","volume":"15","author":"Jokinen","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t20180226040359_awx310-B34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nicl.2014.11.015","article-title":"Basal forebrain atrophy correlates with amyloid \u03b2 burden in Alzheimer\u2019s disease","volume":"7","author":"Kerbler","year":"2015","journal-title":"Neuroimage Clin"},{"key":"key\n\t\t\t\t20180226040359_awx310-B35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-132345","article-title":"Subregional basal forebrain atrophy in Alzheimer\u2019s disease: a multicenter study","volume":"40","author":"Kilimann","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key\n\t\t\t\t20180226040359_awx310-B36","first-page":"1841","article-title":"Parallel atrophy of cortex and basal forebrain cholinergic system in mild cognitive impairment","volume":"27","author":"Kilimann","year":"2017","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20180226040359_awx310-B37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/WNL.0b013e318224af8d","article-title":"Quantitative EEG as a predictive biomarker for Parkinson disease dementia","volume":"77","author":"Klassen","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B38","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.neuroimage.2008.12.037","article-title":"Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration","volume":"46","author":"Klein","year":"2009","journal-title":"Neuroimage"},{"key":"key\n\t\t\t\t20180226040359_awx310-B39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/mp.2016.18","article-title":"Genome-wide significant risk factors for Alzheimer\u2019s disease: role in progression to dementia due to Alzheimer\u2019s disease among subjects with mild cognitive impairment","volume":"22","author":"Lacour","year":"2017","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.04.009","article-title":"Cognitive decline and quality of life in incident Parkinson\u2019s disease: the role of attention","volume":"27","author":"Lawson","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/jnnp-2016-315099","article-title":"Stability of mild cognitive impairment in newly diagnosed Parkinson\u2019s disease","volume":"88","author":"Lawson","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.parkreldis.2014.03.009","article-title":"Subcortical grey matter changes in untreated, early stage Parkinson\u2019s disease without dementia","volume":"20","author":"Lee","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jnnp-2013-305062","article-title":"Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson\u2019s disease","volume":"85","author":"Lee","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B46","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","article-title":"Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"138","author":"Mak","year":"2015","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B47","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20180226040359_awx310-B49","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson\u2019s disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0091-3057(96)00431-5","article-title":"Acetylcholine, aging, and Alzheimer\u2019s disease","volume":"56","author":"Muir","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"key\n\t\t\t\t20180226040359_awx310-B51","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B52","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0000000000000483","article-title":"Initial cognitive decline is associated with cortical thinning in early Parkinson disease","volume":"82","author":"Pereira","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006504.pub2","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease","author":"Rolinski","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180226040359_awx310-B54","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-2010-101011","article-title":"The effect of MAPT H1 and APOE \u025b4 on transition from mild cognitive impairment to dementia","volume":"22","author":"Samaranch","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"key\n\t\t\t\t20180226040359_awx310-B55","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/ncomms13249","article-title":"Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer\u2019s pathology","volume":"7","author":"Schmitz","year":"2016","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20180226040359_awx310-B56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1474-4422(17)30043-1","article-title":"Cognitive decline before diagnosis of Parkinson\u2019s disease - Authors\u2019 reply","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B57","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1750-3639.2009.00370.x","article-title":"Biomarkers for cognitive impairment in Parkinson disease","volume":"20","author":"Shi","year":"2010","journal-title":"Brain Pathol Zurich Switz"},{"key":"key\n\t\t\t\t20180226040359_awx310-B58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B59","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180226040359_awx310-B60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.26907","article-title":"Molecular imaging to track Parkinson\u2019s disease and atypical parkinsonisms: new imaging frontiers","volume":"32","author":"Strafella","year":"2017","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20180226040359_awx310-B61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S1355617715000995","article-title":"Measuring cortical connectivity in Alzheimer\u2019s disease as a brain neural network pathology: toward clinical applications","volume":"22","author":"Teipel","year":"2016","journal-title":"J Int Neuropsychol Soc"},{"key":"key\n\t\t\t\t20180226040359_awx310-B62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neurobiolaging.2013.09.029","article-title":"Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer\u2019s disease","volume":"35","author":"Teipel","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0197-4580(90)90056-6","article-title":"Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer\u2019s disease","volume":"11","author":"Vogels","year":"1990","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B65","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","article-title":"Neurodegeneration across stages of cognitive decline in Parkinson disease","volume":"68","author":"Weintraub","year":"2011","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B66","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180226040359_awx310-B68","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180226040359_awx310-B69","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","article-title":"Association between MAPT haplotype and memory function in patients with Parkinson\u2019s disease and healthy aging individuals","volume":"36","author":"Winder-Rhodes","year":"2015","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20180226040359_awx310-B70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cercor\/bht210","article-title":"Neurons in the basal forebrain project to the cortex in a complex topographic organization that reflects corticocortical connectivity patterns: an experimental study based on retrograde tracing and 3D reconstruction","volume":"25","author":"Zaborszky","year":"2015","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20180226040359_awx310-B71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2013.597","article-title":"Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease","volume":"70","author":"Ziegler","year":"2013","journal-title":"JAMA Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/141\/1\/165\/24175653\/awx310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T08:59:58Z","timestamp":1570265998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/141\/1\/165\/4712018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx310","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,12,8]]}}}